COMMUNIQUÉS West-GlobeNewswire

-
Zosano Pharma Announces Upcoming Oral and Poster Presentations at the Congress of the International Headache Society
23/08/2019 -
Bravo Recognized as a 2019 NorthCoast 99 Award Winner
23/08/2019 -
Seelos Therapeutics Announces Pricing of $6.7 Million Registered Direct Offering
23/08/2019 -
Rafarma to Commence Production in Thailand; Predicted to Be The Region’s “Cannabis Capital”
23/08/2019 -
The Largest Private Plastic and Reconstructive Surgery Practice in the U.S. Welcomes Dr. Irena Karanetz as the 20th Physician at Long Island Plastic Surgical Group
23/08/2019 -
Genprex (GNPX) Featured in Broadcast Discussing Strength, Potential of Biotech Sector
23/08/2019 -
HST Global, Inc. Announces Entering into an Agreement to Purchase a Financial Services Revenue Sharing Contract.
23/08/2019 -
Intercept to Present at Upcoming Investor Conferences in September
23/08/2019 -
BeyondSpring’s Plinabulin Demonstrates Superior Quality of Life Over Pegfilgrastim in a Head-to-Head Comparison Trial for the Prevention of Neutropenia
23/08/2019 -
BioSyent Releases Q2 and H1 2019 Results
23/08/2019 -
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
23/08/2019 -
Ziopharm Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23/08/2019 -
Hemispherx Biopharma, Inc. Changes Name to AIM ImmunoTech Inc. Reflecting Ampligen’s® Immuno Modulation Progress in Ongoing Oncology Clinical Trials and ME/CFS
23/08/2019 -
Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2020
23/08/2019 -
Ossur Hf : Capital Markets Day on 24 September 2019 in Copenhagen
23/08/2019 -
Periodic update on transaction details related to Philips’ share repurchases
23/08/2019 -
Oasmia ADSs delisted from NASDAQ in the US
23/08/2019 -
Chi-Med Initiates a Phase I Trial of HMPL-523 in Patients with Immune Thrombocytopenia (ITP) in China
23/08/2019 -
MDxHealth: MDxHealth Notice of Interim Results 2019
23/08/2019
Pages